# Transarterial Chemoembolization Using Doxorubicin Beads With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

> **NCT01324076** · PHASE3 · UNKNOWN · sponsor: **University College, London** · enrollment: 412 (estimated)

## Conditions studied

- Liver Cancer

## Interventions

- **DRUG:** doxorubicin-eluting beads
- **DRUG:** sorafenib tosylate
- **OTHER:** laboratory biomarker analysis
- **OTHER:** pharmacogenomic studies
- **OTHER:** pharmacological study
- **PROCEDURE:** quality-of-life assessment

## Key facts

- **NCT ID:** NCT01324076
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-11
- **Primary completion:** 2014-11
- **Final completion:** —
- **Target enrollment:** 412 (ESTIMATED)
- **Last updated:** 2011-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01324076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01324076, "Transarterial Chemoembolization Using Doxorubicin Beads With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01324076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*